Shopping Cart 0
Cart Subtotal
USD 0

Global Nuclear Receptor ROR-Gamma Market Analysis 2013-2018 and Forecast 2019-2024

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 2980

Access to Printed Report; No Soft Copy
Print Option: N/A
Copy Option: N/A
Deliverable Format : Printed Publication/ Book by Post

Hard Copy License
USD 3180

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 5960

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 5960
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase

Details

Snapshot

The global Nuclear Receptor ROR-Gamma market will reach xxx Million USD in 2018 and CAGR xx% 2018-2023. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Nuclear Receptor ROR-Gamma by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):

VPR-66

INV-17

GSK-2981278

BBI-6000

Others

Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):

4SC AG

Advinus Therapeutics Ltd.

Arrien Pharmaceuticals, LLC

Aurigene Discovery Technologies Limited

Biogen, Inc.

Brickell Biotech, Inc.

Bristol-Myers Squibb Company

Celgene Corporation

Genentech, Inc.

Genfit SA

GlaxoSmithKline Plc

Hanmi Pharmaceuticals, Co. Ltd.

Karo Bio AB

Lead Pharma Holding B.V.

Nuevolution AB

Phenex Pharmaceuticals AG

Reata Pharmaceuticals, Inc.

Teijin Pharma Limited

Visionary Pharmaceuticals, Inc.

Vitae Pharmaceuticals, Inc.

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):

Hospital

Clinic

Others

Region Coverage (Regional Production, Demand & Forecast by Countries etc.):

North America (U.S., Canada, Mexico)

Europe (Germany, U.K., France, Italy, Russia, Spain etc.)

Asia-Pacific (China, India, Japan, Southeast Asia etc.)

South America (Brazil, Argentina etc.)

Middle East & Africa (Saudi Arabia, South Africa etc.)

READ MORE

Table Of Content

Scope

Table of Content

1 Industry Overview

1.1 Nuclear Receptor ROR-Gamma Industry

1.1.1 Overview

1.1.2 Development of Nuclear Receptor ROR-Gamma

1.2 Market Segment

1.2.1 Upstream

1.2.2 Downstream

1.3 Cost Analysis

2 Industry Environment

2.1 Policy

2.2 Economics

2.3 Sociology

2.4 Technology

3 Nuclear Receptor ROR-Gamma Market by Type

3.1 By Type

3.1.1 VPR-66

3.1.2 INV-17

3.1.3 GSK-2981278

3.1.4 BBI-6000

3.1.5 Others

3.2 Market Size

3.3 Market Forecast

4 Major Companies List

4.1 4SC AG (Company Profile, Sales Data etc.)

4.2 Advinus Therapeutics Ltd. (Company Profile, Sales Data etc.)

4.3 Arrien Pharmaceuticals, LLC (Company Profile, Sales Data etc.)

4.4 Aurigene Discovery Technologies Limited (Company Profile, Sales Data etc.)

4.5 Biogen, Inc. (Company Profile, Sales Data etc.)

4.6 Brickell Biotech, Inc. (Company Profile, Sales Data etc.)

4.7 Bristol-Myers Squibb Company (Company Profile, Sales Data etc.)

4.8 Celgene Corporation (Company Profile, Sales Data etc.)

4.9 Genentech, Inc. (Company Profile, Sales Data etc.)

4.10 Genfit SA (Company Profile, Sales Data etc.)

4.11 GlaxoSmithKline Plc (Company Profile, Sales Data etc.)

4.12 Hanmi Pharmaceuticals, Co. Ltd. (Company Profile, Sales Data etc.)

4.13 Karo Bio AB (Company Profile, Sales Data etc.)

4.14 Lead Pharma Holding B.V. (Company Profile, Sales Data etc.)

4.15 Nuevolution AB (Company Profile, Sales Data etc.)

4.16 Phenex Pharmaceuticals AG (Company Profile, Sales Data etc.)

4.17 Reata Pharmaceuticals, Inc. (Company Profile, Sales Data etc.)

4.18 Teijin Pharma Limited (Company Profile, Sales Data etc.)

4.19 Visionary Pharmaceuticals, Inc. (Company Profile, Sales Data etc.)

4.20 Vitae Pharmaceuticals, Inc. (Company Profile, Sales Data etc.)

5 Market Competition

5.1 Company Competition

5.2 Regional Market by Company

6 Market Demand

6.1 Demand Situation

6.1.1 Demand in Hospital

6.1.2 Demand in Clinic

6.1.3 Demand in Others

6.2 Regional Demand Comparison

6.3 Demand Forecast

7 Region Operation

7.1 Regional Production

7.2 Regional Market

7.3 by Region

7.3.1 North America

7.3.1.1 Overview

7.3.1.2 by Country (U.S., Canada, Mexico)

7.3.2 Europe

7.3.2.1 Overview

7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)

7.3.3 Asia-Pacific

7.3.3.1 Overview

7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)

7.3.4 South America

7.3.4.1 Overview

7.3.4.2 by Country (Brazil, Argentina etc.)

7.3.5 Middle East & Africa

7.3.5.1 Overview

7.3.5.2 by Country (Saudi Arabia, South Africa etc.)

7.4 Regional Import & Export

7.5 Regional Forecast

8 Marketing & Price

8.1 Price and Margin

8.1.1 Price Trends

8.1.2 Factors of Price Change

8.1.3 Manufacturers Gross Margin Analysis

8.2 Marketing Channel

9 Research Conclusion


List Of Figure

Figure Nuclear Receptor ROR-Gamma Industry Chain Structure

Figure Global Nuclear Receptor ROR-Gamma Market Growth 2013-2018, by Type, in USD Million

Figure North America Nuclear Receptor ROR-Gamma Market, by Company, in 2018

Figure Europe Nuclear Receptor ROR-Gamma Market Market, by Company, in 2018

Figure Asia-Pacific Nuclear Receptor ROR-Gamma Market Market, by Company, in 2018

Figure South America Nuclear Receptor ROR-Gamma Market Market, by Company, in 2018

Figure Middle East & Africa Nuclear Receptor ROR-Gamma Market Market, by Company, in 2018

Figure North America Nuclear Receptor ROR-Gamma Market Size and Growth 2013-2018, in USD Million

Figure Europe Nuclear Receptor ROR-Gamma Market Size and Growth 2013-2018, in USD Million

Figure Asia-Pacific Nuclear Receptor ROR-Gamma Market Size and Growth 2013-2018, in USD Million

Figure South America Nuclear Receptor ROR-Gamma Market Size and Growth 2013-2018, in USD Million

Figure Middle East & Africa Nuclear Receptor ROR-Gamma Market Size and Growth 2013-2018, in USD Million

Figure Marketing Channels Overview


List Of Table

Table Upstream Segment of Nuclear Receptor ROR-Gamma

Table Application Segment of Nuclear Receptor ROR-Gamma

Table Global Nuclear Receptor ROR-Gamma Market 2013-2024, by Application, in USD Million

Table Major Company List of VPR-66

Table Major Company List of INV-17

Table Major Company List of GSK-2981278

Table Major Company List of BBI-6000

Table Major Company List of Others

Table Global Nuclear Receptor ROR-Gamma Market 2013-2018, by Type, in USD Million

Table Global Nuclear Receptor ROR-Gamma Market Forecast 2019-2024, by Type, in USD Million

Table 4SC AG Overview List

Table Nuclear Receptor ROR-Gamma Business Operation of 4SC AG (Sales Revenue, Cost, Gross Margin)

Table Advinus Therapeutics Ltd. Overview List

Table Nuclear Receptor ROR-Gamma Business Operation of Advinus Therapeutics Ltd. (Sales Revenue, Cost, Gross Margin)

Table Arrien Pharmaceuticals, LLC Overview List

Table Nuclear Receptor ROR-Gamma Business Operation of Arrien Pharmaceuticals, LLC (Sales Revenue, Cost, Gross Margin)

Table Aurigene Discovery Technologies Limited Overview List

Table Nuclear Receptor ROR-Gamma Business Operation of Aurigene Discovery Technologies Limited (Sales Revenue, Cost, Gross Margin)

Table Biogen, Inc. Overview List

Table Nuclear Receptor ROR-Gamma Business Operation of Biogen, Inc. (Sales Revenue, Cost, Gross Margin)

Table Brickell Biotech, Inc. Overview List

Table Nuclear Receptor ROR-Gamma Business Operation of Brickell Biotech, Inc. (Sales Revenue, Cost, Gross Margin)

Table Bristol-Myers Squibb Company Overview List

Table Nuclear Receptor ROR-Gamma Business Operation of Bristol-Myers Squibb Company (Sales Revenue, Cost, Gross Margin)

Table Celgene Corporation Overview List

Table Nuclear Receptor ROR-Gamma Business Operation of Celgene Corporation (Sales Revenue, Cost, Gross Margin)

Table Genentech, Inc. Overview List

Table Nuclear Receptor ROR-Gamma Business Operation of Genentech, Inc. (Sales Revenue, Cost, Gross Margin)

Table Genfit SA Overview List

Table Nuclear Receptor ROR-Gamma Business Operation of Genfit SA (Sales Revenue, Cost, Gross Margin)

Table GlaxoSmithKline Plc Overview List

Table Nuclear Receptor ROR-Gamma Business Operation of GlaxoSmithKline Plc (Sales Revenue, Cost, Gross Margin)

Table Hanmi Pharmaceuticals, Co. Ltd. Overview List

Table Nuclear Receptor ROR-Gamma Business Operation of Hanmi Pharmaceuticals, Co. Ltd. (Sales Revenue, Cost, Gross Margin)

Table Karo Bio AB Overview List

Table Nuclear Receptor ROR-Gamma Business Operation of Karo Bio AB (Sales Revenue, Cost, Gross Margin)

Table Lead Pharma Holding B.V. Overview List

Table Nuclear Receptor ROR-Gamma Business Operation of Lead Pharma Holding B.V. (Sales Revenue, Cost, Gross Margin)

Table Nuevolution AB Overview List

Table Nuclear Receptor ROR-Gamma Business Operation of Nuevolution AB (Sales Revenue, Cost, Gross Margin)

Table Phenex Pharmaceuticals AG Overview List

Table Nuclear Receptor ROR-Gamma Business Operation of Phenex Pharmaceuticals AG (Sales Revenue, Cost, Gross Margin)

Table Reata Pharmaceuticals, Inc. Overview List

Table Nuclear Receptor ROR-Gamma Business Operation of Reata Pharmaceuticals, Inc. (Sales Revenue, Cost, Gross Margin)

Table Teijin Pharma Limited Overview List

Table Nuclear Receptor ROR-Gamma Business Operation of Teijin Pharma Limited (Sales Revenue, Cost, Gross Margin)

Table Visionary Pharmaceuticals, Inc. Overview List

Table Nuclear Receptor ROR-Gamma Business Operation of Visionary Pharmaceuticals, Inc. (Sales Revenue, Cost, Gross Margin)

Table Vitae Pharmaceuticals, Inc. Overview List

Table Nuclear Receptor ROR-Gamma Business Operation of Vitae Pharmaceuticals, Inc. (Sales Revenue, Cost, Gross Margin)

Table Global Nuclear Receptor ROR-Gamma Sales Revenue 2013-2018, by Company, in USD Million

Table Global Nuclear Receptor ROR-Gamma Sales Revenue Share, by Company, in USD Million

Table Nuclear Receptor ROR-Gamma Demand in Hospital, 2013-2018, in USD Million

Table Major Consumers in Hospital

Table Nuclear Receptor ROR-Gamma Demand in Clinic, 2013-2018, in USD Million

Table Major Consumers in Clinic

Table Nuclear Receptor ROR-Gamma Demand in Others, 2013-2018, in USD Million

Table Major Consumers in Others

Table Regional Demand Comparison List

Table Major Application in Different Regions

Table Nuclear Receptor ROR-Gamma Demand Forecast 2019-2024, by Application, in USD Million

Table Nuclear Receptor ROR-Gamma Production 2013-2018, by Region, in USD Million

Table Global Nuclear Receptor ROR-Gamma Market 2013-2018, by Region, in USD Million

Table Global Nuclear Receptor ROR-Gamma Market Share 2013-2018, by Region, in USD Million

Table North America Nuclear Receptor ROR-Gamma Market Size 2013-2018, by Country, in USD Million

Table Europe Nuclear Receptor ROR-Gamma Market Size 2013-2018, by Country, in USD Million

Table Asia-Pacific Nuclear Receptor ROR-Gamma Market Size 2013-2018, by Country, in USD Million

Table South America Nuclear Receptor ROR-Gamma Market Size 2013-2018, by Country, in USD Million

Table Middle East & Africa Nuclear Receptor ROR-Gamma Market Size 2013-2018, by Country, in USD Million

Table Nuclear Receptor ROR-Gamma Market Forecast 2019-2024, by Region, in USD Million

Table Price Factors List

Licence Rights

"Single User License
allow one user to read, print, and edit the report

Enterprise License
allow all employees within client's company, to read, print, edit the report"

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com